---
source:
  family: "MDCG"
  title: "md_mdcg_2018_7_languages_en"
  path: "02.MDCG/Unique Device Identifier (UDI)/md_mdcg_2018_7_languages_en.pdf"
  pages: 3
  converted: 2026-02-27
  method: pdftotext
---

Medical Devices
Medical Devices Coordination Group Document

MDCG 2018-7

MDCG 2018-7
Provisional considerations regarding language
issues associated with the UDI database
(Annex VI, Part A Section 2 and Part B of the
Medical Device Regulation (EU) 2017/745 (MDR)
and the In-Vitro Diagnostic Medical Device
Regulation (EU) 2017/746 (IVDR))
October 2018

This document has been endorsed by the Medical Device Coordination Group
(MDCG) established by Article 103 of Regulation (EU) 2017/745. The MDCG is
composed of representatives of all Member States and it is chaired by a
representative of the European Commission.
The document is not a European Commission document and it cannot be regarded
as reflecting the official position of the European Commission. Any views expressed
in this document are not legally binding and only the Court of Justice of the European
Union can give binding interpretations of Union law.

Page 1 of 3

Medical Devices
Medical Devices Coordination Group Document

MDCG 2018-7

General principles
In consideration of the following:
- In accordance with Article 28(3) MDR and Article 25(3) IVDR, the core data
elements to be provided to the UDI database shall be accessible to the public,
- Annex VI Part C of the MDR and IVDR on the UDI System requires explicitly in its
section 5.10 that the user interface of the UDI database shall be available in all
official languages of the Union and that the use of free- text fields shall, however, be
minimized in order to reduce translations,
- one of the main declared purposes of the European database on medical devices
(Eudamed) as per Recitals 43-46 and Article 33(1a) of the MDR and Recitals 40-43
of the IVDR is to enable the public (including the healthcare professionals) to be
adequately informed about devices placed on the market,
it is essential that the information in the UDI database is publicly available and easily
understandable by any European citizen.

Use of free-text and translation
Among the UDI core data elements of Part B of Annex VI of the MDR and IVDR, only
three data elements ("Additional product description", "Storage and handling
conditions" and "Critical warnings or contra-indications") are expected to have a freetext format, while a fourth data element (nomenclature term) is associated with a text
allowing to understand the meaning of the associated code (description).
As to the nomenclature, ideally, all the terms/description associated with the
nomenclature codes should be translated in the different Union official languages.
However, it could be also considered having terms available only in English,
particularly taking into account that the nomenclature will have a code. Appropriate
budget and legal verifications will be made on this matter, in the context of the
designation procedure for the new nomenclature.
Among the three data elements that use free-text, one is an optional field: "Additional
product description". It should be provided in English as well as in the languages of
those countries where the device is made available. A data field will be available for
each relevant language.
For the data elements "Storage and handling conditions" and "Critical warnings or
contra-indications", relevant information (as per Annex I Section 23.2 of the MDR and
Annex I Section 20.2 of the IVDR: (k) "any special storage and/or handling
conditions" and (m) "warning or precautions to be taken") should be provided in
Page 2 of 3

Medical Devices
Medical Devices Coordination Group Document

MDCG 2018-7

English as well as in the languages of those countries where the device is made
available. It shall be noted that, as laid down in the provisional guidance related to
formats and definitions of UDI data elements, only storage/handling conditions and
critical warnings or contra-indications, that are required to be on the label, shall be
transmitted to the UDI database. With respect to those two data elements, the
possibility to use (in EUDAMED) â€“ as an alternative option - symbols and/or list of
reference that can categorise and provide enough information understandable by
anyone is currently being explored.

Indication of hazardous substances (only applicable for MDR)
For CMR substances, the Commission intends to explore the feasibility for
EUDAMED to provide the list of official CMR1 substances (from CLP Regulation2)
available in the ECHA3 database. The CAS number4, EC number and/or official
chemical name could be used to identify those substances.
With regard to endocrine disruptor substances, pending verification that an official
database managed by the Commission containing these substances is available, a
solution is currently being explored.
Information to be provided is known by the economic operator in charge of the
submission as it shall be displayed on the device label (Annex I Section 23.2 (f) of the
MDR).

1

CMR stands for carcinogenic, mutagenic, or toxic for reproduction
Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (the 'CLP
Regulation')
3
The European Chemicals Agency
4
A CAS Registry Number, also referred to as CASRN or CAS Number, is a unique numerical identifier assigned by
the Chemical Abstracts Service (CAS) to every chemical substance described in the open scientific literature
2

Page 3 of 3


